Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta-glucan's Immuno-modulatory Effect on Non-Small Cell Lung Cancer

NCT00682032 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.

NCT NCT00682032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00682032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta-glucan's Immuno-modulatory Effect on Non-Small Cell Lung Cancer
Lead sponsor
University of Louisville
Phase
Not applicable
Overall status
Recruiting
Start date
October 31, 2008
Completion date
March 31, 2029
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer